Sales for the third quarter of 2023 were 248.6 million EUR, an increase of 13% compared to the same quarter of the previous year and an increase of 5% compared to the previous quarter. The EUR/USD exchange rate evolution had a negative impact of 3% on sales compared to the same quarter of last year and no impact on sales compared to the previous quarter. The gross result was 114.5 million EUR or 46.1% of sales, an increase of 16% compared to the same quarter of last year and an increase of 3% compared to the previous quarter. R&D expenses were 10.7% of sales, G&A was at 4.8% of sales and Selling was at 2.0% of sales. The operating result was 71.1 million EUR or 28.6% of sales, an increase of 16% compared to the same quarter of last year and an increase of 5% compared to the previous quarter. The net result was 56.8 million EUR or 1.41 EUR per share, an increase of 16% compared to 48.8 million EUR or 1.21 EUR per share in the third quarter of 2022 and an increase of 9% compared to the previous quarter.

see & read more on
https://www.melexis.com/en/news/2023/financial/melexis-q3-2023-results

tijd 11.17
Melexis EUR70,70 +30 ct vol. 5.619